NO970784L - Procedure for maintaining teeth and oral bone - Google Patents

Procedure for maintaining teeth and oral bone

Info

Publication number
NO970784L
NO970784L NO970784A NO970784A NO970784L NO 970784 L NO970784 L NO 970784L NO 970784 A NO970784 A NO 970784A NO 970784 A NO970784 A NO 970784A NO 970784 L NO970784 L NO 970784L
Authority
NO
Norway
Prior art keywords
procedure
oral bone
maintaining teeth
teeth
maintaining
Prior art date
Application number
NO970784A
Other languages
Norwegian (no)
Other versions
NO970784D0 (en
Inventor
William Sales
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO970784L publication Critical patent/NO970784L/en
Publication of NO970784D0 publication Critical patent/NO970784D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Fremgangsmåte for opprettholdelse av tenner og oralt ben, omfattende administrering til et menneske som trenger dette, en effektiv mengde av en forbindelse med formel (1) OCHjCHj-rJ R^O' 0) hvor R^ og r3 uavhengig er hydrogen, -CH3, (a) eller (b), hvor Ar eventuelt er substituert fenyl; R^ er valgt fra gruppen omfattende pyrrolidon, heksametylenimino og piperidino; eller et farmasøytisk akseptabelt salt eller solvat derav.A method of maintaining teeth and oral bone, comprising administering to a human in need thereof, an effective amount of a compound of formula (1) OCH 2 CH 2 - R (a) or (b), wherein Ar is optionally substituted phenyl; R 1 is selected from the group consisting of pyrrolidone, hexamethylenimino and piperidino; or a pharmaceutically acceptable salt or solvate thereof.

NO970784A 1994-08-22 1997-02-20 Procedure for maintaining teeth and oral bone NO970784D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29423794A 1994-08-22 1994-08-22
PCT/US1995/010582 WO1996005829A1 (en) 1994-08-22 1995-08-21 Methods of maintaining teeth and oral bone

Publications (2)

Publication Number Publication Date
NO970784L true NO970784L (en) 1997-02-20
NO970784D0 NO970784D0 (en) 1997-02-20

Family

ID=23132491

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970784A NO970784D0 (en) 1994-08-22 1997-02-20 Procedure for maintaining teeth and oral bone

Country Status (14)

Country Link
EP (1) EP0769946A4 (en)
JP (1) JPH10504573A (en)
KR (1) KR970705386A (en)
AU (1) AU692598B2 (en)
CA (1) CA2198108A1 (en)
CZ (1) CZ52197A3 (en)
FI (1) FI970713A (en)
HU (1) HUT76891A (en)
IL (1) IL115017A0 (en)
MX (1) MX9701331A (en)
NO (1) NO970784D0 (en)
WO (1) WO1996005829A1 (en)
YU (1) YU55495A (en)
ZA (1) ZA956987B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss

Also Published As

Publication number Publication date
HUT76891A (en) 1997-12-29
AU3408895A (en) 1996-03-14
CA2198108A1 (en) 1996-02-29
YU55495A (en) 1998-07-10
FI970713A0 (en) 1997-02-20
ZA956987B (en) 1997-02-21
AU692598B2 (en) 1998-06-11
KR970705386A (en) 1997-10-09
IL115017A0 (en) 1995-12-08
JPH10504573A (en) 1998-05-06
FI970713A (en) 1997-02-20
EP0769946A1 (en) 1997-05-02
MX9701331A (en) 1997-05-31
EP0769946A4 (en) 1997-11-05
WO1996005829A1 (en) 1996-02-29
CZ52197A3 (en) 1997-08-13
NO970784D0 (en) 1997-02-20

Similar Documents

Publication Publication Date Title
IL111288A (en) Uses of 2-phenyl-3-aroylbenzothiophenes and 3-phenyl-4-aroyl-1,2-dihydronaphthalenes for the preparation of a medicament for inhibiting smooth muscle cell proliferation and restinosis
NO944911L (en) Non-peptide takykininreseptorantagonister
HUT71344A (en) Pharmaceutical compositions for inhibiting thrombin containing 2-phenyl-3-aroyl-benzothiophene derivatives and process for their preparation
IL111284A (en) 2-phenyl-3-aroylbenzothiophenes for use as medicaments for inhibiting endometriosis
DK0771200T3 (en) Use of raloxifene and its analogues in the manufacture of a medicament for the treatment of viral diseases
DK0651999T3 (en) Methods for inhibiting uterine fibrosis
DK0652000T3 (en) Use of 2-phenyl-3-aroylbenzothiophenes for the preparation of a drug for inhibiting angiogenesis and angiogenic diseases
MX9701325A (en) Methods of inhibiting ulcerative mucositis.
MX9701360A (en) Methods of inhibiting demyelinating and dysmyelinating diseases.
DK0659417T3 (en) Methods for inhibiting dysfunctional uterine bleeding
DK0652002T3 (en) Use of 2-phenyl-3-aroylebenzothiophenes in the manufacture of a drug for inhibiting cartilage degradation
NO970786L (en) Procedure for inhibiting bone degradation
NO970784L (en) Procedure for maintaining teeth and oral bone
NO971794L (en) Method of inhibiting states associated with bradykinin
DK0769945T3 (en) Use of 2-phenyl-3-aroylbenzothiophene derivatives for the manufacture of a medicament for the treatment of bone and bone fractures
NO971029L (en) Methods for inhibiting endometrial metoses
NO973103L (en) Method for inhibiting growth hormone effects
DK0771201T3 (en) Use of 2-phenyl-3-aroylbenzothiophenes to prepare a drug for inhibiting primary endometrial hyperplasia
MX9709536A (en) Methods of inducing bef-1 transcription factor.